These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16707596)

  • 21. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
    Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
    Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogenic down-regulation of protein tyrosine phosphatase gamma (PTP gamma) in human breast is associated with estrogen receptor alpha.
    Liu S; Sugimoto Y; Kulp SK; Jiang J; Chang HL; Park KY; Kashida Y; Lin YC
    Anticancer Res; 2002; 22(6C):3917-23. PubMed ID: 12553013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
    Jiang J; Slivova V; Sliva D
    Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisphenol-A and estradiol exert novel gene regulation in human MCF-7 derived breast cancer cells.
    Singleton DW; Feng Y; Chen Y; Busch SJ; Lee AV; Puga A; Khan SA
    Mol Cell Endocrinol; 2004 Jun; 221(1-2):47-55. PubMed ID: 15223131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional cyclin D1 overexpression or hypoxia correlate inversely with heterogeneous oestrogen receptor-alpha expression in human breast cancer.
    Kronblad A; Helczynska K; Nielsen NH; Påhlman E; Emdin S; Påhlman S; Landberg G
    In Vivo; 2003; 17(4):311-8. PubMed ID: 12929585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of novel ER-alpha target genes in breast cancer cells: gene- and cell-selective co-regulator recruitment at target promoters determines the response to 17beta-estradiol and tamoxifen.
    Romano A; Adriaens M; Kuenen S; Delvoux B; Dunselman G; Evelo C; Groothuis P
    Mol Cell Endocrinol; 2010 Jan; 314(1):90-100. PubMed ID: 19698761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells.
    Frankel LB; Lykkesfeldt AE; Hansen JB; Stenvang J
    Breast Cancer Res Treat; 2007 Aug; 104(2):165-79. PubMed ID: 17061041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer.
    Rokavec M; Schroth W; Amaral SM; Fritz P; Antoniadou L; Glavac D; Simon W; Schwab M; Eichelbaum M; Brauch H
    Cancer Res; 2008 Dec; 68(23):9799-808. PubMed ID: 19047159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Angiogenic effect of interleukin-8 in breast cancer and its association with estrogen receptor].
    Lin Y; Wang SM; Huang RP
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1419-23. PubMed ID: 16029657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.
    Wolf I; O'Kelly J; Rubinek T; Tong M; Nguyen A; Lin BT; Tai HH; Karlan BY; Koeffler HP
    Cancer Res; 2006 Aug; 66(15):7818-23. PubMed ID: 16885386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of estradiol, raloxifene and tamoxifen on estrogen receptor expression in cultured human skin fibroblasts.
    Haczynski J; Tarkowski R; Jarzabek K; Wolczynski S; Magoffin DA; Czarnocki KJ; Ziegert M; Jakowicki J; Jakimiuk AJ
    Int J Mol Med; 2004 Jun; 13(6):903-8. PubMed ID: 15138633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor.
    Levenson AS; Svoboda KM; Pease KM; Kaiser SA; Chen B; Simons LA; Jovanovic BD; Dyck PA; Jordan VC
    Cancer Res; 2002 Aug; 62(15):4419-26. PubMed ID: 12154049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An intracellular anti-erbB-2 single-chain antibody is specifically cytotoxic to human breast carcinoma cells overexpressing erbB-2.
    Wright M; Grim J; Deshane J; Kim M; Strong TV; Siegal GP; Curiel DT
    Gene Ther; 1997 Apr; 4(4):317-22. PubMed ID: 9176517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
    Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
    Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
    Chen J; Power KA; Mann J; Cheng A; Thompson LU
    Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiologic levels of 2-methoxyestradiol interfere with nongenomic signaling of 17beta-estradiol in human breast cancer cells.
    Vijayanathan V; Venkiteswaran S; Nair SK; Verma A; Thomas TJ; Zhu BT; Thomas T
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2038-48. PubMed ID: 16609013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
    Liu ZJ; Zhu BT
    J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterization of breast cancer cell lines by a low-density microarray.
    de Longueville F; Lacroix M; Barbuto AM; Bertholet V; Gallo D; Larsimont D; Marcq L; Zammatteo N; Boffe S; Leclercq G; Remacle J
    Int J Oncol; 2005 Oct; 27(4):881-92. PubMed ID: 16142302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen receptor-alpha regulates the degradation of insulin receptor substrates 1 and 2 in breast cancer cells.
    Morelli C; Garofalo C; Bartucci M; Surmacz E
    Oncogene; 2003 Jun; 22(26):4007-16. PubMed ID: 12821935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
    Girgert R; Hanf V; Emons G; Gründker C
    J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.